Similar articles

• [The desogestrel-ethinyl estradiol combination and overweight: current data].

  Rubio Lotvin B. Rubio Lotvin B. Ginecol Obstet Mex. 1995 Nov;63:483-6. Ginecol Obstet Mex. 1995. PMID: 8537039 Spanish.
• Ovarian activity and bleeding patterns during extended continuous use of a combined contraceptive vaginal ring.

  Davies GC, Feng LX, Newton JR, Dieben TO, Coelingh-Bennink HJ. Davies GC, et al. Contraception. 1992 Sep;46(3):269-78. doi: 10.1016/0010-7824(92)90007-g. Contraception. 1992. PMID: 1451522
• Developments in contraception: a comprehensive review of Desogen (desogestrel and ethinyl estradiol).

  Lammers P, Blumenthal PD, Huggins GR. Lammers P, et al. Contraception. 1998 May;57(5 Suppl):1S-27S. doi: 10.1016/s0010-7824(98)00030-4. Contraception. 1998. PMID: 9673846 Review. No abstract available.
• The 3-keto-desogestrel/ethinylestradiol ring: a new parenteral form of hormonal contraception.

  Schindler AE. Schindler AE. Eur J Obstet Gynecol Reprod Biol. 1993 Apr;49(1-2):13-4. doi: 10.1016/0028-2243(93)90101-h. Eur J Obstet Gynecol Reprod Biol. 1993. PMID: 8365506 Clinical Trial. No abstract available.
• [The latest progestagens].

  Belaïsch J, Eliakim V. Belaïsch J, et al. Contracept Fertil Sex. 1993 Apr;21(4):287-93. Contracept Fertil Sex. 1993. PMID: 7951628 Review. French.